OSE Immunotherapeutics (XPAR:OSE) Beginning Cash Position : €15.02 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Beginning Cash Position?

OSE Immunotherapeutics's Beginning Cash Position for the quarter that ended in Dec. 2023 was €15.02 Mil.

OSE Immunotherapeutics's quarterly Beginning Cash Position declined from Dec. 2022 (€31.19 Mil) to Jun. 2023 (€25.62 Mil) and declined from Jun. 2023 (€25.62 Mil) to Dec. 2023 (€15.02 Mil).

OSE Immunotherapeutics's annual Beginning Cash Position increased from Dec. 2021 (€29.37 Mil) to Dec. 2022 (€33.58 Mil) but then declined from Dec. 2022 (€33.58 Mil) to Dec. 2023 (€25.62 Mil).

OSE Immunotherapeutics Beginning Cash Position Historical Data

The historical data trend for OSE Immunotherapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Beginning Cash Position Chart

OSE Immunotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

9.57

25.84

29.37

33.58

25.62

OSE Immunotherapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															27.26	33.58	31.19	25.62	15.02

OSE Immunotherapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

OSE Immunotherapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics (XPAR:OSE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

6OP:Germany

Address

22, Boulevard Benoni Goullin, Nantes, FRA, 44200

Website

http://www.ose-immuno.com

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics (XPAR:OSE) Headlines

No Headlines